Stock Risk Measures for Aimmune Therapeutics Inc

1. Company Info - Description, identity and sector data.
2. Share Data - Stock earnings and key dates.
3. Market Risk - Beta, size, liquidity and momentum measures.
4. Financial Risk - Earnings and dividends.

/ factorpad.com / stocks / f42kdq.html

AIMT Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Aimmune Therapeutics Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how AIMT stock compares to 2,000+ US-based stocks, and to peers in the Health Technology sector and Biotechnology industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA.

Identity

• Symbol: AIMT
• FactorPad FPID: f42kdq
• SEC CIK: 0001631650
• Share Class FIGI: BBG005NMB2M3
• Location: Brisbane, CA US
• Web: http://www.aimmune.com
• Employees: 275

Sector and Industry

• Sector: Health Technology
• Industry: Biotechnology
• SIC Code: 2834

Share Data

Shares and Float

• Shares Outstanding: 65,450,100
• Shares Trading: 51,958,478
• Percent Trading: 79.4 %

Earnings and Dividends

• Trailing 12-month earnings: -4.49
• Next earnings date: 2020-11-04

• Dividends in last 12 months: None
• Ex-dividend date: None

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

• Beta: 0.99 | All: 30 | Sector: 60 | Industry: 53

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

• Market Capitalization: $2,254,755,945 | All: 61 | Sector: 61 | Industry: 58

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

• Daily Dollar Volume: $116,092,681 | All: 20 | Sector: 25 | Industry: 19

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

• Stock Price Change (1-Year): 68.3% | All: 7 | Sector: 19 | Industry: 31

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

• Earnings Yield (E/P): -13.04% | All: 90 | Sector: 86 | Industry: 77

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

• Dividend Yield (D/P): 0% | All: 84 | Sector: 61 | Industry: 54

/ factorpad.com / stocks / f42kdq.html